Background The present study assesses the time intervals from symptom discovery to
treatment start and describes the health service use experiences of uninsured patients with …

Los diseños de investigación se refieren a la forma como se obtiene la información y están
limitados por viabilidad ética, económica y temporal. Son estrategias estandarizadas para …

Breast cancer is a heterogeneous pathology, but the genomic basis of its variability remains
poorly understood in populations other than Caucasians. Here, through DNA and RNA …

Studies have suggested a potential role of somatic mitochondrial mutations in cancer
development. To analyze the landscape of somatic mitochondrial mutation in breast cancer …

Patients with triple-negative breast cancer (TNBC) have a poor prognosis, partly because of
the absence of targeted therapies. Recognition of the key role of immune responses against …

Background Essential indicators of health system performance for breast cancer are lacking
in Mexico. We estimated survival and clinical stage distribution for women without social …

Cancer incidence and mortality are increasing in low-and middle-income countries (LMICs),
where more than 75% of global cancer burden will occur by the year 2040. The primary …

PURPOSE The financial toxicity (FT) of cancer is common among older adults in high-
income countries, but little is known about the financial hardships faced by older patients …

Purpose The aim of this study was to compare the difference in disease-free survival (DFS)
and overall survival (OS) between invasive lobular carcinoma (ILC) and invasive ductal …

Objetivo: identificar marcadores clínico-patológicos y moleculares como predictores de la
supervivencia en pacientes con cáncer de mama localmente avanzado (CMLA). Material y …